a close up of a pen


Sandoz broadens its pharmaceutical portfolio with acquisition of Euro-Pharm product line

Date closed: 6/1/2016

Value: C$17 million

On June 1st, 2016, Sandoz AG purchased the North American distribution rights and portfolio of pharmaceutical and natural health products owned by Euro – Pharm International Canada Inc.

This portfolio acquisition allows Sandoz to promote EURO-PHARM's products in Canada starting June 1, 2016. EURO-PHARM, a privately-owned company founded in Montreal in 1996, will continue to manufacture the products for Sandoz and retains certain rights to commercialize products outside North America.

BLG represented Sandoz Canada Inc./Sandoz AG with a team led by Louis Clément that included Yaniv Saragosti, Manon Gauthier and Kenza Bensaid.